DRUG · Mapped RxNorm record
risperidone
Normalized identity: risperidoneView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Antipsychotic to Treat Psychosis Syndrome
NCT02137616
Drugs and interventions used in this trial
4 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
olanzapine
Normalized identity: olanzapineView linked drug · Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
Quetiapine
Normalized identity: quetiapineView linked drug · Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
Aripiprazole
Normalized identity: aripiprazoleView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedAntipsychotic to Treat Psychosis Syndrome
Design: INTERVENTIONAL · Status: UNKNOWN · Phase: NA
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Psychotic Disordersunresolved
Interventions
risperidoneDRUG · verified · RxNorm: risperidone
olanzapineDRUG · verified · RxNorm: olanzapine
QuetiapineDRUG · verified · RxNorm: quetiapine
AripiprazoleDRUG · verified · RxNorm: aripiprazole
Sponsors & collaborators
Central South Universitylead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02137616 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.